BioPorto Diagnostics
Emilija Rukšėnaitė is a biomedical scientist at BioPorto Diagnostics A/S since January 2022, with prior experience as an R&D intern and MSc thesis student at EpiBiologics. Emilija's academic background includes an MSc in Biotechnology from DTU - Technical University of Denmark, expected in February 2024, and a BSc in Biochemistry from The University of Edinburgh, completed in 2015. Previously, Emilija worked as an academic employee at the Novo Nordisk Foundation Center for Protein Research and held positions as a research assistant and bachelor thesis student at The University of Edinburgh, as well as an intern in clinical biochemistry at SYNLAB Lietuva UAB. Emilija has also received the International BioInnovation Scholarship.
BioPorto Diagnostics
2 followers
BioPorto Diagnostics - Buy antibodies, immunoassays and a market-leading acute kidney injury biomarker, The NGAL Test - use both human urine and plasma.